Jeff Dunkel explains why being at O=MEGA23 in Melbourne was important for Eyetelligence – and how he hopes to drive success for this Australian-based artificial intelligence company that’s developing screening solutions for the medical industry. With a massive AU$18 million investment from the United States, it’s all about growth to improve healthcare outcomes.
